1.
Özkan E, Köksal M, Ece B, Koyun M, Kuzu Ömer F, Açıkgöz Y, et al. Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC. Radiol Oncol [Internet]. 2025 Dec. 16 [cited 2026 Apr. 16];59(4):624-3. Available from: https://www.radioloncol.com/index.php/ro/article/view/4685